Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

VCs Like China and Biotech for 2008

publication date: Feb 1, 2008

A survey conducted among industry insiders picks China as the ex-US country likely to pocket the most in VC dollars over the course of 2008. In terms of industries, 15% of the respondents said biopharma would be the recipient of the largest amount of new investments. That was good for a solid second place, as 24% of those surveyed predicted that greentech/cleantech would garner the top industry spot. The respondents also noted a deep-seated change in venture capital investing, as the sector increasingly sees private equity funds active in the space. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital